Tel Aviv - Delayed Quote ILA
Lineage Cell Therapeutics, Inc. (LCTX.TA)
173.80
+15.20
+(9.86%)
As of 4:41:36 PM GMT+3. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.25M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Feb 11, 2025 |
| SAMUEL GEORGE A. III General Counsel | -- | Direct | -- | Feb 11, 2025 |
| SAMUEL GEORGE A. III General Counsel | Purchase at price 0.60 per share. | Direct | 9,000 | Nov 26, 2024 |
| HOWE JILL ANN Chief Financial Officer | Purchase at price 0.59 per share. | Direct | 8,850 | Nov 26, 2024 |
| MULROY MICHAEL H Director | Purchase at price 0.57 per share. | Direct | 22,640 | Nov 22, 2024 |
| CULLEY BRIAN M Chief Executive Officer | Purchase at price 0.60 per share. | Direct | 24,000 | Nov 21, 2024 |
| HOWE JILL ANN Chief Financial Officer | Purchase at price 0.89 per share. | Direct | 9,345 | Aug 16, 2024 |
| CULLEY BRIAN M Chief Executive Officer | Purchase at price 1.05 per share. | Direct | 10,500 | May 24, 2024 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Feb 9, 2024 |
| SAMUEL GEORGE A. III General Counsel | -- | Direct | -- | Feb 9, 2024 |
| BAILEY DON MATTHEW Director | Purchase at price 1.04 per share. | Indirect | 100,001 | Feb 8, 2024 |
| BROADWOOD PARTNERS, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.04 per share. | Direct | 7,000,001 | Feb 6, 2024 |
| JAYASURIYA ANULA Director | Purchase at price 1.09 per share. | Direct | 10,900 | Dec 29, 2023 |
Related Tickers
CGEN.TA Compugen Ltd.
515.20
-3.97%
ENLV.TA Enlivex Therapeutics Ltd.
321.40
-2.78%
BLRX.TA BioLineRx Ltd.
1.8000
+5.88%
EVGN.TA Evogene Ltd.
399.50
-5.11%
NERV Minerva Neurosciences, Inc.
1.7900
+1.13%
CGEN Compugen Ltd.
1.4306
-0.66%
PPBT Purple Biotech Ltd
2.7350
+1.30%
BLRX BioLineRx Ltd.
2.9267
-2.44%
CLDX Celldex Therapeutics, Inc.
19.43
-0.03%
EVGN Evogene Ltd.
1.0650
-2.33%